Our recent observations suggest that the abnormal activation of mTOR may contribute to apoptosis signaling pathways and premature activation of mechanisms of neurodegeneration in both FCD type II and TSC [48]. The gene discussed is MTOR; the disease is isolated focal cortical dysplasia type II.